User:Dawei20/akrx

Akorn, Inc. (NASDAQ: AKRX) is an American pharmaceutical company specializing in the development and manufacture of a specialized range of products, primarily in the areas of ophthalmic solutions and injectable antibiotics. Its headquarters is in Lake Forest, Illinois, with additional locations in Illinois and New Jersey.

History
Akorn was founded in Abita Springs, Louisiana in 1971 as Akorn Ophthalmics.

By 2009 the company was struggling financially and its future was in doubt. A new CEO, Raj Rai, was hired and immediately the company turned profitable, increasing its market capitalization to ten times its 2009 value by early 2012.

Revenue source: http://www.marketwatch.com/story/akorn-reports-2011-fourth-quarter-and-year-end-financial-results-2012-03-06

Raj Rai source: http://articles.chicagotribune.com/2012-01-15/business/ct-biz-0115-akorn--20120115_1_akorn-injectable-share

Its strong recent growth and perceived potential for future growth have earned it the attention of many professional investors and hedge fund managers: http://seekingalpha.com/article/578211-6-cash-heavy-small-cap-healthcare-stocks-rated-as-buys

http://www.dailypolitical.com/finance/stock-market/needham-company-reaffirms-buy-rating-on-akorn-akrx.htm

http://seekingalpha.com/article/584261-21-undervalued-highly-shorted-stocks-being-bought-up-by-hedge-funds